ILMN Long Put Strategy

ILMN (Illumina, Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.

Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific.

ILMN (Illumina, Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $26.71B, a trailing P/E of 31.67, a beta of 1.49 versus the broader market, a 52-week range of 88-182.84, average daily share volume of 1.7M, a public-listing history dating back to 2000, approximately 9K full-time employees. These structural characteristics shape how ILMN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.49 indicates ILMN has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long put on ILMN?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current ILMN snapshot

As of June 30, 2026, spot at $177.55, ATM IV 43.00%, IV rank 17.90%, expected move 12.33%. The long put on ILMN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this long put structure on ILMN specifically: ILMN IV at 43.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a ILMN long put, with a market-implied 1-standard-deviation move of approximately 12.33% (roughly $21.89 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ILMN expiries trade a higher absolute premium for lower per-day decay. Position sizing on ILMN should anchor to the underlying notional of $177.55 per share and to the trader's directional view on ILMN stock.

ILMN long put setup

The ILMN long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ILMN near $177.55, the first option leg uses a $180.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ILMN chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ILMN shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$180.00$7.50

ILMN long put risk and reward

Net Premium / Debit
-$750.00
Max Profit (per contract)
$17,249.00
Max Loss (per contract)
-$750.00
Breakeven(s)
$172.50
Risk / Reward Ratio
22.999

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

ILMN long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on ILMN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

ILMN long put profit and loss curve at expiration with breakevens and current spot markedILMN long put payoff at expiration$0$5000$10000$15000$50$100$150$200$250$300$350Underlying Price ($)P&L at Expiration ($)BE $172.50Spot $177.55
P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.
Underlying Price% From SpotP&L at Expiration
$0.01-100.0%+$17,249.00
$39.27-77.9%+$13,323.38
$78.52-55.8%+$9,397.76
$117.78-33.7%+$5,472.15
$157.03-11.6%+$1,546.53
$196.29+10.6%-$750.00
$235.55+32.7%-$750.00
$274.80+54.8%-$750.00
$314.06+76.9%-$750.00
$353.32+99.0%-$750.00

When traders use long put on ILMN

Long puts on ILMN hedge an existing long ILMN stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ILMN exposure being hedged.

ILMN thesis for this long put

The market-implied 1-standard-deviation range for ILMN extends from approximately $155.66 on the downside to $199.44 on the upside. A ILMN long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long ILMN position with one put per 100 shares held. Current ILMN IV rank near 17.90% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ILMN at 43.00%. As a Healthcare name, ILMN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ILMN-specific events.

ILMN long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ILMN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ILMN alongside the broader basket even when ILMN-specific fundamentals are unchanged. Long-premium structures like a long put on ILMN are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ILMN chain quotes before placing a trade.

Frequently asked questions

What is a long put on ILMN?
A long put on ILMN is the long put strategy applied to ILMN (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With ILMN stock trading near $177.55, the strikes shown on this page are snapped to the nearest listed ILMN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ILMN long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the ILMN long put priced from the end-of-day chain at a 30-day expiry (ATM IV 43.00%), the computed maximum profit is $17,249.00 per contract and the computed maximum loss is -$750.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ILMN long put?
The breakeven for the ILMN long put priced on this page is roughly $172.50 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ILMN market-implied 1-standard-deviation expected move is approximately 12.33%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on ILMN?
Long puts on ILMN hedge an existing long ILMN stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ILMN exposure being hedged.
How does current ILMN implied volatility affect this long put?
ILMN ATM IV is at 43.00% with IV rank near 17.90%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related ILMN analysis